Tag: access trial

Eritoran does not decrease mortality during severe sepsis [The ACCESS Trial]

bys25qthea

March 19, 2013

Image: PD 1. Previous phase I and phase II trials in severe sepsis patients show the lipopolysaccharide antagonist eritoran decreases ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

#VisualAbstract: Inebilizumab Improves Outcomes in Generalized Myasthenia Gravis
Ultrasound-guided radiofrequency ablation may be effective for treatment of aldosterone-producing adenomas
#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

No Result

View All Result